Thermostable mRNA Vaccines using Hybrid Polymer-Lipid Nanoparticles
- Presenting a polymer-based nanoparticles for vaccines and therapeutics
- Highlighting 12-month stability data of liquid formulations at 2 – 80°C and improvements related to anti-PEG antibodies and response durability
- Outlining a CEPI funded rabies mRNA vaccine program